N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide

C125H136F3N33O15S3 — CID 157337227

About N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide

N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide (PubChem CID 157337227) has the molecular formula C125H136F3N33O15S3 and a molecular weight of 2493.87 g/mol. Its IUPAC name is N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide.

Molecular Properties

• Compound Name: N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide
• PubChem CID: 157337227
• Molecular Formula: C125H136F3N33O15S3
• Molecular Weight: 2493.87 g/mol
• Exact Mass: 2492.00
• IUPAC Name: N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide
• SMILES: CN1CCN(c2nc3cc(N4CCCCC4)c(NC(=O)c4csc(-c5ccn[nH]5)n4)cc3o2)CC1.Cc1cc(-c2ccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCC(F)CC3)o2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCN(C)CC5)nc4cc3N3CCCCC3)cs2)ccn1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(F)CC1)c1ccc(-c2cn[nH]c2)o1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(F)CC1)c1csc(-c2cn[nH]c2)n1
• InChI: InChI=1S/C27H28FN5O4.C27H31N7O2S.C24H25FN6O4.C24H28N8O2S.C23H24FN7O3S/c1-17-14-18(4-7-29-17)23-2-3-24(36-23)26(34)30-20-16-25-21(15-22(20)32-8-5-19(28)6-9-32)31-27(37-25)33-10-12-35-13-11-33;1-18-14-19(6-7-28-18)26-30-22(17-37-26)25(35)29-20-16-24-21(15-23(20)33-8-4-3-5-9-33)31-27(36-24)34-12-10-32(2)11-13-34;25-16-3-5-30(6-4-16)19-11-18-22(35-24(29-18)31-7-9-33-10-8-31)12-17(19)28-23(32)21-2-1-20(34-21)15-13-26-27-14-15;1-30-9-11-32(12-10-30)24-28-18-13-20(31-7-3-2-4-8-31)17(14-21(18)34-24)26-22(33)19-15-35-23(27-19)16-5-6-25-29-16;24-15-1-3-30(4-2-15)19-9-17-20(34-23(29-17)31-5-7-33-8-6-31)10-16(19)27-21(32)18-13-35-22(28-18)14-11-25-26-12-14/h2-4,7,14-16,19H,5-6,8-13H2,1H3,(H,30,34);6-7,14-17H,3-5,8-13H2,1-2H3,(H,29,35);1-2,11-14,16H,3-10H2,(H,26,27)(H,28,32);5-6,13-15H,2-4,7-12H2,1H3,(H,25,29)(H,26,33);9-13,15H,1-8H2,(H,25,26)(H,27,32)
• InChIKey: BFYWRPKUCFKCHD-UHFFFAOYSA-N
• XLogP: 20.68
• TPSA: 518.99 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 43
• Rotatable Bonds: 25
• Heavy Atoms: 179
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2493.87
LogP ≤ 5	20.68
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	43

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?

The IUPAC name of N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide (CID 157337227) is N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide.

What is the SMILES notation for N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?

The canonical SMILES for N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide is CN1CCN(c2nc3cc(N4CCCCC4)c(NC(=O)c4csc(-c5ccn[nH]5)n4)cc3o2)CC1.Cc1cc(-c2ccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCC(F)CC3)o2)ccn1.Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCN(C)CC5)nc4cc3N3CCCCC3)cs2)ccn1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(F)CC1)c1ccc(-c2cn[nH]c2)o1.O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(F)CC1)c1csc(-c2cn[nH]c2)n1.

What is the InChIKey of N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?

The InChIKey is BFYWRPKUCFKCHD-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H28FN5O4.C27H31N7O2S.C24H25FN6O4.C24H28N8O2S.C23H24FN7O3S/c1-17-14-18(4-7-29-17)23-2-3-24(36-23)26(34)30-20-16-25-21(15-22(20)32-8-5-19(28)6-9-32)31-27(37-25)33-10-12-35-13-11-33;1-18-14-19(6-7-28-18)26-30-22(17-37-26)25(35)29-20-16-24-21(15-23(20)33-8-4-3-5-9-33)31-27(36-24)34-12-10-32(2)11-13-34;25-16-3-5-30(6-4-16)19-11-18-22(35-24(29-18)31-7-9-33-10-8-31)12-17(19)28-23(32)21-2-1-20(34-21)15-13-26-27-14-15;1-30-9-11-32(12-10-30)24-28-18-13-20(31-7-3-2-4-8-31)17(14-21(18)34-24)26-22(33)19-15-35-23(27-19)16-5-6-25-29-16;24-15-1-3-30(4-2-15)19-9-17-20(34-23(29-17)31-5-7-33-8-6-31)10-16(19)27-21(32)18-13-35-22(28-18)14-11-25-26-12-14/h2-4,7,14-16,19H,5-6,8-13H2,1H3,(H,30,34);6-7,14-17H,3-5,8-13H2,1-2H3,(H,29,35);1-2,11-14,16H,3-10H2,(H,26,27)(H,28,32);5-6,13-15H,2-4,7-12H2,1H3,(H,25,29)(H,26,33);9-13,15H,1-8H2,(H,25,26)(H,27,32).

What are the key properties of N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?

N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide has a molecular weight of 2493.87 g/mol, XLogP of 20.68, 25 rotatable bonds, 8 hydrogen bond donors, and 43 hydrogen bond acceptors.

Where does this data come from?

All data for N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(2-methyl-4-pyridinyl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide;N-[5-(4-fluoropiperidin-1-yl)-2-morpholin-4-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-4-yl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-thiazole-4-carboxamide;N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide is sourced from PubChem (CID 157337227), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).